DexCom
DXCM
#934
Rank
$24.51 B
Marketcap
$62.85
Share price
0.96%
Change (1 day)
-7.97%
Change (1 year)

Operating Margin for DexCom (DXCM)

Operating Margin as of March 2026 (TTM): 23.34%

According to DexCom's latest financial reports and stock price the company's current Operating Margin is 23.34%. At the end of 2025 the company had an Operating Margin of 23.35%.

Operating Margin history for DexCom from 2006 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202523.35%32.8%
202417.58%-10.36%
202319.61%46.02%
202213.43%28.05%
202110.49%-10.19%
202011.68%65.42%
20197.06%-157.57%
2018-12.26%81.29%
2017-6.76%-40.25%
2016-11.32%-20.86%
2015-14.30%66.25%
2014-8.60%-53.81%
2013-18.63%-66.66%
2012-55.86%-4.66%
2011-58.58%-48.42%
2010-113.58%-36.99%
2009-180.26%-66.43%
2008-536.97%-46.77%
2007-1,008.77%-55.62%
2006-2,272.81%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 48.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
19.09%-18.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78%-28.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
8.98%-61.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
21.31%-8.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-19.14%-182.01%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-41.85%-279.31%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
19.54%-16.28%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.